Helen Gipson
Family · Memphis, TNNPI 1164616058
Payments from drug & device makers
Across 194 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$526
- AbbVie$385
- Pfizer$384
- Biohaven Pharmaceutical Holding Company Ltd.$255
- Acadia Pharmaceuticals Inc$244
- Lundbeck LLC$200
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,14298%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $526 |
| AbbVie | 13 | $385 |
| Pfizer | 24 | $384 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $255 |
| Acadia Pharmaceuticals Inc | 12 | $244 |
| Lundbeck LLC | 11 | $200 |
| Impel Pharmaceuticals Inc. | 9 | $200 |
| SK Life Science, Inc. | 2 | $190 |
| Otsuka America Pharmaceutical, Inc. | 8 | $179 |
| Lilly USA, LLC | 11 | $160 |
| Neurocrine Biosciences, Inc. | 7 | $153 |
| Sanofi | 7 | $148 |
| Acorda Therapeutics, Inc | 6 | $141 |
| MDD US Operations, LLC | 5 | $120 |
| Corium, LLC | 7 | $107 |
| AstraZeneca | 5 | $91 |
| Novartis | 3 | $89 |
| Amneal Pharmaceuticals LLC | 5 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $71 |
| Avanir Pharmaceuticals, Inc. | 3 | $69 |
| Catalyst Pharmaceuticals, Inc. | 2 | $52 |
| Neurelis, Inc. | 2 | $50 |
| Argenx US, Inc. | 2 | $46 |
| Upsher-smith Laboratories LLC | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| UCB, Inc. | 1 | $33 |
| Amgen | 2 | $28 |
| Eisai Inc. | 1 | $27 |
| CSL Behring | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Si-bone, Inc. | 1 | $24 |
| Amylyx Pharmaceuticals, Inc. | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
How this compares
$4,236 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 39 | $1,738 |
| Gabapentin | 16 | $805 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $698 |
| Phenytoin Sodium Extended | 16 | $324 |
| Atorvastatin Calcium | 35 | $303 |
| Zonisamide | 15 | $168 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $149 |
| Donepezil Hcl | 13 | $90 |
| Amitriptyline Hcl | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other family in Memphis
- Marye BernardMemphis$128K
- Brett SnodgrassMemphis$47K
- John ScallionsMemphis$30K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.